1
|
Hoda M Marzouk, Amira S Gouda, Mamdouh R Rezk, Ahmed M Abdel-Megied “Innovative eco-friendly stability-indicating HPLC-PDA method for simultaneous determination of the emerging antiviral drugs against COVID-19 infection molnupiravir and favipiravir; degradation kinetic studies along with LC-MS based structure elucidation” Microchemical J. 2024; 205, 111197. https://doi.org/10.1016/j.microc.2024.111197 (Q1, IF 5.3).
|
2
|
Galal Magdy, Amira A Al-enna, Fathalla Belal, Ramadan A El-Domany, Ahmed M Abdel-Megied “Quality-by-design optimized RP-HPLC approach for the therapeutic drug monitoring of glibenclamide and fluoxetine in human plasma” Microchemical J. 2024; 201, 110548. https://doi.org/10.1016/j.microc.2024.110548 (Q1, IF 5.3).
|
3
|
Hoda M Marzouk, Amira S Gouda, Mamdouh R Rezk, Ahmed M Abdel-Megied “A validated LC-MS/MS method for determination of Molnupiravir and Favipiravir in human plasma; Assessment of the remarkable potential synergistic effect against SARS-CoV-2 Infection: Application to a pharmacokinetic study in healthy Egyptian volunteers”. Microchemical J. 2024; 197, 109815. https://doi.org/10.1016/j.microc.2023.109815 (Q1, IF 5.3).
|
4
|
Rania Elkeeb, Anomeh Avartoomian, Amira S Gouda, Ahmed M Abdel-Megied, Ola Abdallah, Eman Atef “PBPK Evaluation of Sofosbuvir Dose in Pediatrics Using Simcyp®” Sci. Pharm. 2023, 91(3), 38;. https://doi.org/10.3390/scipharm91030038 (Q2, IF: 2.5).
|
5
|
Ahmed M. Abdel‑Megied, Isaac A. Monreal, Limian Zhao, Alex Apffel, Hector C. Aguilar, Jace W. Jones “Characterization of the cellular lipid composition during SARS‑CoV‑2 infection” Anal Bioanal Chem. 2023, 415, 5269–5279. https://doi.org/10.1007/s00216-023-04825-1 (Q1, IF: 4.3).
|
6
|
Galal Magdy, Amira A Al-Enna, Fathalla Belal, Ramadan A El-Domany, Ahmed M Abdel-Megied “Analytical quality-by-design approach for development and validation of HPLC method for the simultaneous estimation of omarigliptin, metformin, and ezetimibe: application to human plasma and dosage forms” BMC Chemistry. 2023, 17, 45. https://doi.org/10.1186/s13065-023-00955-w (Q2, IF: 4.6).
|
7
|
Amira S Gouda, Hoda M Marzouk, Mamdouh R Rezk, Ahmed M Abdel-Megied “Ecofriendly stability-indicating UHPLC-PDA method for determination of the new influenza antiviral prodrug Baloxavir Marboxil; Application to degradation kinetic studies and structure elucidation of the major degradation products using LC-MS” Sust Chem & Pharm. 2023, 33, 101093. https://doi.org/10.1016/j.scp.2023.101093 (Q1, IF: 6.0).
|
8
|
A Salem, A Gouda, H Marzouk, M Rezk, A M. Abdel-Megied “A Population Pharmacokinetic Modelling Approach to Evaluate the Current Dosing Recommendations of Favipiravir in Egyptian Subjects” Int J Infect Dis. 2023, 130, S94. https://doi.org/10.1016/j.ijid.2023.04.234 (Q1, IF: 12.0).
|
9
|
Ahmed M Abdel‐Megied, Sergiy Kovalenko, Fawzy A Elbarbry, Marjan Piponski, Oleksandra Oleshchuk, Sami El Deeb, Galal Magdy, Fathalla Belal, Taras Grochovuy, Liliya Logoyda “LC‐MS/MS Bioanalytical Method for the Quantitative Analysis of Nifedipine, Bisoprolol, and Captopril in Human Plasma: Application to Pharmacokinetic Studies”. J Biomed Chromatogr. 2023; Online Record: e5664. https://doi.org/10.1002/bmc.5664 (Q2, IF: 1.8).
|
10
|
Amira S Gouda, Ahmed M Abdel-Megied, Mamdouh R Rezk, Hoda M Marzouk “LC-MS/MS-based metabolite quantitation of the antiviral prodrug baloxavir marboxil, a new therapy for acute uncomplicated influenza, in human plasma: Application to a human pharmacokinetic study” J Pharm Biomed Anal. 2023, 20, 115165. https://doi.org/10.1016/j.jpba.2022.115165 (Q2, IF: 3.4)
|
|